Novel vaccine strategy produces rapid and long-term protection against Chikungunya virus

(The Wistar Institute) New research from The Wistar Institute has demonstrated how a novel vaccine strategy that boosts the immune system by rapidly producing antibodies against CHIKV, combined with a traditional DNA-based vaccine approach, can provide both short term and long term protection against the virus. Study results are published in the Journal of Infectious Diseases.
Source: EurekAlert! - Medicine and Health - Category: Global & Universal Source Type: news